Boston Scientific Corporation BSX
43.92
(0.76)
(1.70%)
as of 25 Sep
- Market cap
- $64.7B
- P/E
- 17.7×
Follow BSX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Boston Scientific Corporation (BSX) Debt to equity
Boston Scientific Corporation's debt to equity at the end of the quarter to 30 June 2026 was 0.5×, up 0.0× from fiscal 2025 (0.5×). Over the past ten years it has ranged from 0.5× (fiscal 2023) to 0.9× (fiscal 2015); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.5× | (4.32%) |
| FY2024 | 0.5× | 4.78% |
| FY2023 | 0.5× | (8.34%) |
| FY2022 | 0.5× | (6.77%) |
| FY2021 | 0.5× | (8.58%) |
| FY2020 | 0.6× | (17.28%) |
| FY2019 | 0.7× | (10.81%) |
| FY2018 | 0.8× | 0.96% |
| FY2017 | 0.8× | (1.67%) |
| FY2016 | 0.8× | (9.33%) |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.5× | 18.70% |
| Mar 2026 | 0.4× | (9.59%) |
| Dec 2025 | 0.5× | (4.81%) |
| Sep 2025 | 0.5× | (4.03%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.5×
High 0.9×
Ten-year median
0.6×
Current reading's percentile
18
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| EW Edwards Lifesciences Corporation compare | 0.1× |
| STE STERIS plc compare | 0.3× |
| DXCM DexCom, Inc. compare | 0.5× |
| BSX Boston Scientific Corporation | 0.5× |
| PHG Koninklijke Philips N.V. compare | 0.6× |
| MDT Medtronic PLC compare | 0.6× |
| SYK Stryker Corporation compare | 0.6× |
| ABT Abbott Laboratories compare | 0.6× |
| GEHC GE HealthCare Technologies Inc. compare | 1.0× |
| Medical Devices industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on BSX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement